All In MedTech

MAUDE Monitor

Changes in report volume

Device types whose adverse event reports over the last 3 complete months are running above their average for the 12 months before. A rise in reports is a reason to look closer. It is not a finding about the device.

Last checked: Nov 21, 2026Latest source record: Oct 30, 2026 (newest report received)openFDA last updated: Nov 11, 2026Methods & limitations

What a rise can mean

Read this list as a set of questions, not answers.

  • More devices in use. Reports rise with sales, and this data has no count of devices sold or implanted.
  • A change in how reports are filed. One manufacturer filing a backlog, or switching to summary reporting, can move a whole device type.
  • A recall, a safety notice, a lawsuit or news coverage, each of which prompts people to report older events.
  • A real change in how the device performs. The counts alone cannot tell you which of these it is.

Comparing Aug 1, 2026 to Oct 31, 2026 with Aug 1, 2025 to Jul 31, 2026, Endocrinology & Diabetes Technology. The newest months can still grow as FDA processes reports, so the recent figures may be undercounts.

Largest increases in report volume

Device types at 25% or more above their earlier monthly average, among the 100 most-reported device types in the last 3 months. Up to 25 are listed, largest change first.

All 20 device types checked

Every device type with at least 30 reports in the last 3 months, most reports first. Falls and flat lines are shown as well as rises.

Show the full table
Device typeReports per month, last 3 monthsReports per month, 12 months beforeChangeReports
Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)72,23944,151+64%Open
Alternate Controller Enabled Insulin Infusion Pump (QFG)36,51832,622+12%Open
Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems (QLG)32,9342,182+1,409%Open
Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)8,734273+3,104%Open
Automated Insulin Dosing Device System, Single Hormonal Control (OZP)8,59611,934-28%Open
Sensor, Glucose, Invasive, Non-Adjunctive (PQF)1,2862,763-53%Open
Pump, Infusion, Insulin (LZG)880933-6%Open
Interoperable Automated Glycemic Controller (QJI)838247+240%Open
Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)750305+146%Open
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)716917-22%Open
System, Test, Blood Glucose, Over The Counter (NBW)523397+32%Open
Integrated Continuous Glucose Monitoring System With Sensor Containing Dexamethasone Acetate (SBA)307218+41%Open
Sensor, Glucose, Invasive (MDS)159255-37%Open
Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter (SAF)106114-8%Open
Interoperable Automated Glycemic Controller, Insulin Suspend (QJS)99.77.7+1,200%Open
Automated Insulin Dosing , Threshold Suspend (OZO)93.0170-45%Open
Sensor, Glucose, Implanted, Non-Adjunctive Use (QHJ)44.048.5-9%Open
Continuous Glucose Monitor Retrospective Data Analysis Software (PHV)23.316.3+43%Open
Insulin Pump Secondary Display (PKU)20.7434-95%Open
Prescription Use Blood Glucose Meter For Near-Patient Testing (PZI)19.74.2+372%Open

Back to the MAUDE Monitor

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.